Aval
Technology Adoption Platform
My requestsNew requestNotificationsMy profile
Your role: Requestor
Each role sees a different working world. Switching lands on that persona's home screen.
Fairhaven General Hospital — Demo
Brantwood, ON · 260 beds
Demo environment — fictional data. Holds no patient-level information by design.
← Back to case
Download PDF
the Aval
Technology adoption decision record & value contract
Fairhaven General Hospital — Demo
Brantwood, ON
AC-2026-002

NPWT standardization to single vendor

Negative-pressure wound therapy — single-vendor consolidation — WoundTech Pro · Wound Care · requested by Jenna Kowalski, NP, Nov 18, 2025
Approved with conditions
Feb 10, 2026

Standardization delivers material savings and training simplification with no clinical downside identified in evaluation. Total organizational value clearly positive.

Conditions of approval
  • Unit pricing not to exceed proposal rates (CPI-indexed cap)
  • Quarterly utilization and complication report to committee for first year
Committee record: 8 for · 1 against · 1 abstentions
Problem addressed

Three NPWT vendors in-house: triple inventory, inconsistent training, premium rental pricing on two contracts, and avoidable dressing-change frequency on legacy systems.

Standard replaced or augmented

Mixed fleet across three NPWT vendors (rental + consumables).

Evidence basis
  • NPWT platform equivalence review
  • Consolidated pricing proposal (vendor-supplied)
  • Inventory & training burden analysis
  • Health Canada licence
Value profile at decision
Clinical impact3/5 · w30%
Safety2/5 · w25%
Financial materiality4/5 · w20%
Workflow disruption3/5 · w15%
Organizational risk2/5 · w10%
Net annual impact: +$83K/yr (assumptions on case file)
Value contract
Frozen Feb 10, 2026 · reviews at 90 / 180 / 365 days · immutable
We approved this technology expectingBaselineExpected
Dressing changes per patient-week4.2 /wk≤ 3 /wk
Nursing minutes per change12 min≤ 10 min
Wound complication rate3.1 %≤ 3.1 %
Annual NPWT category spend486,000 $≤ 403,000 $
Clinician adoption0 %≥ 80 %
Rosa Delgado
Chief Nursing Executive
Alan Chen
VP, Supply Chain & Facilities
This Aval is the permanent institutional record of this adoption decision: what was decided, on what evidence, by whom, and against which expected outcomes it will be measured. Audit trail: 6 events on file. Generated by Aval — Aug 13, 2026. Contains no patient-level information.